{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:42:36Z","timestamp":1792604556456,"version":"4.5.0"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>High fasting plasma glucose (HFPG) is an established risk factor for breast cancer (BC). However, accurate and up-to-date estimates of the global burden of breast cancer attributable to high fasting plasma glucose (BC-HFPG) are scarce. This study aims to provide a comprehensive analysis of the burden of BC-HFPG using data from the Global Burden of Disease (GBD) database from 1990 to2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a comprehensive descriptive analysis of the burden of female BC-HFPG based on the GBD 2023 database. The core metrics analyzed were the absolute number of death and disability-adjusted life years (DALY). To ensure comparability across populations with differing age structures, we also analyzed the age-standardized mortality rate (ASMR) and the age-standardized DALY rate (ASDR). The average annual percent change (AAPC) was used to further comprehensively describe the burden of disease and its changing trends. In addition to the retrospective analysis from 1990 to 2023, we used the Bayesian age-period-cohort (BAPC) model to generate predicted data on the burden of female BC-HFPG from 2024 to 2050.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Female BC-HFPG accounted for 48,307 deaths and 1,406,186 DALYs globally in 2023. From 1990 to 2023, the global ASMR and ASDR of female BC-HFPG showed overall upward trends, with an average annual percentage change (AAPC) of 0.28% (95% CI: 0.18% to 0.38%) for ASMR and 0.44% (95% CI: 0.37% to 0.51%) for ASDR; the two rates increased from 0.92 and 26.22 per 100,000 in 1990 to 1.00 and 30.17 per 100,000 in 2023, respectively. The burden varied substantially across the 21 GBD regions and 204 countries and territories in 2023. In 2023, SDI was only weakly correlated with ASMR (Spearman \u03c1\u2009=\u20090.20, P\u2009=\u20090.004) and not significantly correlated with ASDR, and the burden peaked in low-middle SDI quintile countries. The BAPC model projected that the ASMR and ASDR of female BC-HFPG would continue to rise from 2024 to 2050.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The global burden of female BC-HFPG increased from 1990 to 2023 and is projected to continue rising through 2050, disproportionately affecting low- and low-middle SDI regions. These findings suggest that glycemic management and metabolic risk-factor control warrant consideration within comprehensive breast cancer prevention frameworks. However, because this is an ecological, population-level analysis, whether glucose lowering interventions can reduce breast cancer incidence remains to be established in prospective interventional studies. Our results may help prioritize regions and populations for future etiological and intervention research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0359268","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:23:06Z","timestamp":1792603386000},"page":"e0359268","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["The global burden of female breast cancer attributable to high fasting plasma glucose: A comprehensive analysis of the GBD database from 1990 to 2023"],"prefix":"10.1371","volume":"21","author":[{"given":"Huadi","family":"Shi","sequence":"first","affiliation":[{"name":"Affiliated Hospital of Guangdong Medical University","place":["Zhanjiang, Guangdong Province, China"]},{"name":"Third Division General Hospital, Xinjiang Production and Construction Corps","place":["Tumushuke, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Song","sequence":"additional","affiliation":[{"name":"Zhanjiang Central Hospital, Guangdong Medical University","place":["Zhanjiang, Guangdong Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Chen","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Guangdong Medical University","place":["Zhanjiang, Guangdong Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Third Division General Hospital, Xinjiang Production and Construction Corps","place":["Tumushuke, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9069-2025","authenticated-orcid":true,"given":"Yuling","family":"Song","sequence":"additional","affiliation":[{"name":"Zhanjiang Central Hospital, Guangdong Medical University","place":["Zhanjiang, Guangdong Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"issue":"3","key":"pone.0359268.ref001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"10286","key":"pone.0359268.ref002","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"S Loibl","year":"2021","journal-title":"Lancet"},{"issue":"23","key":"pone.0359268.ref003","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1200\/JCO.22.00519","article-title":"Systemic therapy for advanced human epidermal growth factor receptor 2-positive breast cancer: ASCO guideline update","volume":"40","author":"SH Giordano","year":"2022","journal-title":"J Clin Oncol"},{"issue":"5","key":"pone.0359268.ref004","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1470-2045(11)70030-4","article-title":"Preventive therapy for breast cancer: A consensus statement","volume":"12","author":"J Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"issue":"5","key":"pone.0359268.ref005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"D Hanahan","year":"2011","journal-title":"Cell"},{"issue":"2","key":"pone.0359268.ref006","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism","volume":"11","author":"RA Cairns","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"pone.0359268.ref007","first-page":"1061","article-title":"Association between diabetes mellitus and breast cancer risk: A meta-analysis of the literature","volume":"12","author":"S Liao","year":"2011","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"pone.0359268.ref008","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.293.2.194","article-title":"Fasting serum glucose level and cancer risk in Korean men and women","volume":"293","author":"SH Jee","year":"2005","journal-title":"JAMA"},{"issue":"10440","key":"pone.0359268.ref009","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","journal-title":"Lancet"},{"issue":"6","key":"pone.0359268.ref010","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1038\/s41591-025-03624-8","article-title":"Global, regional and national burden of dietary iron deficiency from 1990 to 2021: A Global Burden of Disease study","volume":"31","author":"GBD 2021 Dietary Iron Deficiency Collaborators","year":"2025","journal-title":"Nat Med"},{"key":"pone.0359268.ref011","doi-asserted-by":"crossref","first-page":"1473548","DOI":"10.3389\/fneur.2025.1473548","article-title":"Temporal and geographical dynamics of early-onset Parkinson\u2019s disease burden: Insights from the Global Burden of Disease Study 2021","volume":"16","author":"Y Li","year":"2025","journal-title":"Front Neurol"},{"key":"pone.0359268.ref012","doi-asserted-by":"crossref","first-page":"102996","DOI":"10.1016\/j.eclinm.2024.102996","article-title":"Global assessment of leukemia care quality: Insights from the quality of care index (QCI) from 1990 to 2021","volume":"79","author":"Y Pan","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"2","key":"pone.0359268.ref013","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11892-012-0356-6","article-title":"The links between insulin resistance, diabetes, and cancer","volume":"13","author":"E Orgel","year":"2013","journal-title":"Curr Diab Rep"},{"issue":"11","key":"pone.0359268.ref014","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1210\/en.2018-00574","article-title":"Diabetes, obesity, and breast cancer","volume":"159","author":"C Kang","year":"2018","journal-title":"Endocrinology"},{"issue":"2","key":"pone.0359268.ref015","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-18-0037","article-title":"Metabolic reprogramming in type 2 diabetes and the development of breast cancer","volume":"237","author":"SD Martin","year":"2018","journal-title":"J Endocrinol"},{"issue":"4","key":"pone.0359268.ref016","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s13402-016-0282-8","article-title":"High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells","volume":"39","author":"LA Flores-L\u00f3pez","year":"2016","journal-title":"Cell Oncol"},{"key":"pone.0359268.ref017","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ctrv.2018.08.004","article-title":"Challenges and perspectives in the treatment of diabetes associated breast cancer","volume":"70","author":"SM Samuel","year":"2018","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"pone.0359268.ref018","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clon.2014.10.006","article-title":"Need for radiotherapy in low and middle income countries \u2013 the silent crisis continues","volume":"27","author":"EH Zubizarreta","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"8","key":"pone.0359268.ref019","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S2213-8587(17)30181-X","article-title":"Diabetes in sub-Saharan Africa: From clinical care to health policy","volume":"5","author":"R Atun","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"pone.0359268.ref020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgo.2012.03.024","article-title":"Meeting the emerging challenge of breast and cervical cancer in low- and middle-income countries","volume":"119","author":"FM Knaul","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"issue":"11","key":"pone.0359268.ref021","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2213-8587(16)30181-4","article-title":"Diabetes diagnosis and care in sub-Saharan Africa: Pooled analysis of individual data from 12 countries","volume":"4","author":"J Manne-Goehler","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"pone.0359268.ref022","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/annonc\/mdr297","article-title":"Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: Combined analysis of CALGB 9342 and 9840","volume":"23","author":"SM Lichtman","year":"2012","journal-title":"Ann Oncol"},{"issue":"8","key":"pone.0359268.ref023","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000556","article-title":"Cardiovascular disease and breast cancer: Where these entities intersect: a scientific statement from the American Heart Association","volume":"137","author":"LS Mehta","year":"2018","journal-title":"Circulation"},{"key":"pone.0359268.ref024","doi-asserted-by":"crossref","first-page":"155217","DOI":"10.1016\/j.metabol.2022.155217","article-title":"A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on","volume":"133","author":"C Boutari","year":"2022","journal-title":"Metabolism"},{"issue":"1","key":"pone.0359268.ref025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ejcn.2012.171","article-title":"Dietary patterns and type 2 diabetes in Japanese men and women: The Japan Public Health Center-based Prospective Study","volume":"67","author":"A Nanri","year":"2013","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"pone.0359268.ref026","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4048\/jbc.2023.26.e45","article-title":"Artificial intelligence in breast cancer diagnosis and personalized medicine","volume":"26","author":"JS Ahn","year":"2023","journal-title":"J Breast Cancer"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0359268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:23:11Z","timestamp":1792603391000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0359268"}},"subtitle":[],"editor":[{"given":"Pengpeng","family":"Ye","sequence":"first","affiliation":[{"name":"National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention","place":["CHINA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0359268","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]}}}